LOGIN  |  REGISTER
C4 Therapeutics
Viking Therapeutics

LeMaitre Vascular to Participate at Upcoming Investor Conferences in March

March 01, 2024 | Last Trade: US$96.31 1.69 -1.72

BURLINGTON, Mass., March 01, 2024 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will be participating in four upcoming investor conferences in March.

Oppenheimer 34th Annual Healthcare MedTech & Services Conference (Virtual)
Tuesday, March 12, 2024
David Roberts, President, will present at 11:20 AM EDT

Barclays Global Healthcare Conference
Thursday, March 14, 2024
Loews Miami Beach Hotel, Miami Beach, FL
David Roberts, President, will present at 10:15 AM EDT

36th Annual Roth Conference 2024
Tuesday, March 19, 2024
The Ritz Carlton, Laguna Niguel located in Dana Point, CA
JJ Pellegrino, Chief Financial Officer, will present at 11 AM PDT

KeyBanc Life Sciences & MedTech Investor Forum (Virtual)
Wednesday, March 20, 2024
David Roberts, President, will present at 11:15 AM EDT

About LeMaitre

LeMaitre is a provider of devices, implants, and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures, and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. For more information about the Company, please visit www.lemaitre.com.

LeMaitre is a registered trademark of LeMaitre Vascular, Inc.

Terns Pharmaceuticals

Stock Quote

Last Trade: US$96.31
Daily Change: -1.69 -1.72
Daily Volume: 137,175
Market Cap: US$2.170B

Featured Stock

Astria Therapeutics

Astria Therapeutics is a biopharmaceutical company, and our mission is to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Our lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in clinical development...

CLICK TO LEARN MORE

Featured Stock

Recursion

Recursion Pharmaceuticals is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously expands one of the world’s largest....

CLICK TO LEARN MORE

End of content

No more pages to load

Next page